These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

597 related items for PubMed ID: 19004037

  • 1. Elevated serum insulin-like growth factor (IGF-1) and IGF binding protein-3 levels in patients with systemic sclerosis: possible role in development of fibrosis.
    Hamaguchi Y, Fujimoto M, Matsushita T, Hasegawa M, Takehara K, Sato S.
    J Rheumatol; 2008 Dec; 35(12):2363-71. PubMed ID: 19004037
    [Abstract] [Full Text] [Related]

  • 2. Increased serum soluble CD40 levels in patients with systemic sclerosis.
    Komura K, Fujimoto M, Matsushita T, Yanaba K, Kodera M, Kawasuji A, Hasegawa M, Takehara K, Sato S.
    J Rheumatol; 2007 Feb; 34(2):353-8. PubMed ID: 17295440
    [Abstract] [Full Text] [Related]

  • 3. Serum pulmonary and activation-regulated chemokine/CCL18 levels in patients with systemic sclerosis: a sensitive indicator of active pulmonary fibrosis.
    Kodera M, Hasegawa M, Komura K, Yanaba K, Takehara K, Sato S.
    Arthritis Rheum; 2005 Sep; 52(9):2889-96. PubMed ID: 16142750
    [Abstract] [Full Text] [Related]

  • 4. Elevated serum concentrations of triggering receptor expressed on myeloid cells-1 in diffuse cutaneous systemic sclerosis: association with severity of pulmonary fibrosis.
    Tomita H, Ogawa F, Hara T, Yanaba K, Iwata Y, Muroi E, Yoshizaki A, Komura K, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Sato S.
    J Rheumatol; 2010 Apr; 37(4):787-91. PubMed ID: 20156945
    [Abstract] [Full Text] [Related]

  • 5. Increased serum soluble OX40 in patients with systemic sclerosis.
    Komura K, Yoshizaki A, Kodera M, Iwata Y, Ogawa F, Shimizu K, Wayaku T, Yukami T, Murata M, Hasegawa M, Fujimoto M, Takehara K, Sato S.
    J Rheumatol; 2008 Dec; 35(12):2359-62. PubMed ID: 18843780
    [Abstract] [Full Text] [Related]

  • 6. Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis.
    Matsushita T, Hasegawa M, Hamaguchi Y, Takehara K, Sato S.
    J Rheumatol; 2006 Feb; 33(2):275-84. PubMed ID: 16465658
    [Abstract] [Full Text] [Related]

  • 7. Serum soluble CTLA-4 levels are increased in diffuse cutaneous systemic sclerosis.
    Sato S, Fujimoto M, Hasegawa M, Komura K, Yanaba K, Hayakawa I, Matsushita T, Takehara K.
    Rheumatology (Oxford); 2004 Oct; 43(10):1261-6. PubMed ID: 15266059
    [Abstract] [Full Text] [Related]

  • 8. Analysis of insulin like growth factor 1 and insulin like growth factor binding protein 3 levels in bronchoalveolar lavage fluid and serum of patients with lung cancer.
    Unsal E, Köksal D, Yurdakul AS, Atikcan S, Cinaz P.
    Respir Med; 2005 May; 99(5):559-65. PubMed ID: 15823452
    [Abstract] [Full Text] [Related]

  • 9. Elevated circulating TWEAK levels in systemic sclerosis: association with lower frequency of pulmonary fibrosis.
    Yanaba K, Yoshizaki A, Muroi E, Hara T, Ogawa F, Usui A, Hasegawa M, Fujimoto M, Takehara K, Sato S.
    J Rheumatol; 2009 Aug; 36(8):1657-62. PubMed ID: 19531747
    [Abstract] [Full Text] [Related]

  • 10. Circulating levels of active transforming growth factor beta1 are reduced in diffuse cutaneous systemic sclerosis and correlate inversely with the modified Rodnan skin score.
    Dziadzio M, Smith RE, Abraham DJ, Black CM, Denton CP.
    Rheumatology (Oxford); 2005 Dec; 44(12):1518-24. PubMed ID: 16159952
    [Abstract] [Full Text] [Related]

  • 11. Clinical significance of soluble CD31 in patients with systemic sclerosis (SSc): association with limited cutaneous SSc.
    Sato S, Komura K, Hasegawa M, Fujimoto M, Takehara K.
    J Rheumatol; 2001 Nov; 28(11):2460-5. PubMed ID: 11708419
    [Abstract] [Full Text] [Related]

  • 12. Increased serum pentraxin 3 in patients with systemic sclerosis.
    Iwata Y, Yoshizaki A, Ogawa F, Komura K, Hara T, Muroi E, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Takehara K, Sato S.
    J Rheumatol; 2009 May; 36(5):976-83. PubMed ID: 19273457
    [Abstract] [Full Text] [Related]

  • 13. Increased serum interleukin 23 in patients with systemic sclerosis.
    Komura K, Fujimoto M, Hasegawa M, Ogawa F, Hara T, Muroi E, Takehara K, Sato S.
    J Rheumatol; 2008 Jan; 35(1):120-5. PubMed ID: 18085738
    [Abstract] [Full Text] [Related]

  • 14. Adiponectin expression is decreased in the involved skin and sera of diffuse cutaneous scleroderma patients.
    Arakawa H, Jinnin M, Muchemwa FC, Makino T, Kajihara I, Makino K, Honda N, Sakai K, Fukushima S, Ihn H.
    Exp Dermatol; 2011 Sep; 20(9):764-6. PubMed ID: 21615510
    [Abstract] [Full Text] [Related]

  • 15. Can CCL2 serum levels be used in risk stratification or to monitor treatment response in systemic sclerosis?
    Carulli MT, Handler C, Coghlan JG, Black CM, Denton CP.
    Ann Rheum Dis; 2008 Jan; 67(1):105-9. PubMed ID: 17604287
    [Abstract] [Full Text] [Related]

  • 16. Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody.
    Perera A, Fertig N, Lucas M, Rodriguez-Reyna TS, Hu P, Steen VD, Medsger TA.
    Arthritis Rheum; 2007 Aug; 56(8):2740-6. PubMed ID: 17665460
    [Abstract] [Full Text] [Related]

  • 17. Elevated serum BAFF levels in patients with systemic sclerosis: enhanced BAFF signaling in systemic sclerosis B lymphocytes.
    Matsushita T, Hasegawa M, Yanaba K, Kodera M, Takehara K, Sato S.
    Arthritis Rheum; 2006 Jan; 54(1):192-201. PubMed ID: 16385515
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Increased cutaneous T-cell-attracting chemokine levels in sera from patients with systemic sclerosis.
    Hayakawa I, Hasegawa M, Matsushita T, Yanaba K, Kodera M, Komura K, Takehara K, Sato S.
    Rheumatology (Oxford); 2005 Jul; 44(7):873-8. PubMed ID: 15797972
    [Abstract] [Full Text] [Related]

  • 20. Expression of insulin-like growth factor-I and insulin-like growth factor binding proteins during thioacetamide-induced liver cirrhosis in rats.
    Novosyadlyy R, Dargel R, Scharf JG.
    Growth Horm IGF Res; 2005 Oct; 15(5):313-23. PubMed ID: 16098781
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.